ArticleScientific reports2024

Multi-omics pan-cancer study of SPTBN2 and its value as a potential therapeutic target in pancreatic cancer.

Hongliang Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.